Advanced Search

Journal of Traditional Chinese Medicine >

2026 , Vol. 46 >Issue 4: 894 - 906

DOI: https://doi.org/10.19852/j.cnki.jtcm.2026.04.010

Original Articles

Electroacupuncture alleviates intestinal inflammation in rats with ulcerative colitis by regulating colonic cell autophagy and gut microbiota

  • XU Huichao ,
  • HAO Jianheng ,
  • CHANG Boya ,
  • WANG Danni ,
  • LI Rangqian ,
  • CAO Yuxia ,
  • WANG Haijun ,
  • JI Laixi
Expand
  • the Second Clinical College, Shanxi University of Chinese Medicine, Jinzhong 030619, China

Received date: 2025-06-17

  Accepted date: 2025-11-18

  Online published: 2026-08-08

Supported by

National Natural Science Foundation of China: Study on the Regulatory Mechanism of Cellular Autophagy of Acupoint Prescription for Intestinal Diseases in Regulating Intestinal Flora Dysbiosis in Ulcerative Colitis(82074549)

Fold

Abstract

OBJECTIVE: To investigate the effects of electroacupuncture (EA) on autophagy and gut microbiota homeostasis in a dextran sulfate sodium (DSS)-induced rat model of ulcerative colitis (UC).

METHODS: UC rats received EA treatment, and efficacy was evaluated by disease activity index (DAI), colon length, serum cytokines, and histopathology. Autophagy was assessed by transmission electron microscopy (TEM), reverse transcription quantitative polymerase chain reaction, and Western blotting for autophagy-related protein (ATG)5, ATG12, microtubule-associated protein 1 light chain 3 (LC3), and sequestosome 1 (p62), with phosphatidylinositol 3-kinase/protein kinase B/ mammalian target of rapamycin (PI3K/AKT/mTOR) pathway analysis. Gut microbiota composition was profiled by 16S ribosomal RNA (rRNA) gene sequencing, and functional relevance was confirmed by fecal microbiota transplantation (FMT).

RESULTS: EA reduced DAI scores, preserved colon length, lowered tumor necrosis factor-α and interleukin-1β (IL-1β), and elevated IL-2 and IL-10. Colonic injury and inflammatory infiltration were alleviated, autophagy markers improved, and PI3K/AKT/mTOR pathway activity was suppressed. EA also enhanced microbiota diversity and composition, with FMT confirming its microbiota-autophagy-inflammation modulatory role.

CONCLUSION: EA alleviates UC by promoting colonic epithelial autophagy through PI3K/AKT/mTOR pathway inhibition and restoring gut microbiota balance, offering a promising therapeutic strategy.

Key words： electroacupuncture; colitis, ulcerative; autophagy; gastrointestinal microbiome

Cite this article

XU Huichao , HAO Jianheng , CHANG Boya , WANG Danni , LI Rangqian , CAO Yuxia , WANG Haijun , JI Laixi . Electroacupuncture alleviates intestinal inflammation in rats with ulcerative colitis by regulating colonic cell autophagy and gut microbiota[J]. Journal of Traditional Chinese Medicine, 2026 , 46(4) : 894 -906 . DOI: 10.19852/j.cnki.jtcm.2026.04.010

References

1. Kucharzik T, Koletzko S, Kannengiesser K, Dignass A. Ulcerative colitis-diagnostic and therapeutic algorithms. Dtsch Arztebl Int 2020; 117: 564-74.
2. Gros B, Kaplan GG. Ulcerative colitis in adults: a review. JAMA 2023; 330: 951-65.
3. Du L, Ha C. Epidemiology and pathogenesis of ulcerative colitis. Gastroenterol Clin North Am 2020; 49: 643-54.
4. Wei SC, Sollano J, Hui YT, et al. Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia. Expert Rev Gastroenterol Hepatol 2021; 15: 275-89.
5. Yamazaki M, Chung H, Xu Y, Qiu H. Trends in the prevalence and incidence of ulcerative colitis in Japan and the US. Int J Colorectal Dis 2023; 38: 135.
6. Buie MJ, Quan J, Windsor JW, et al. Global hospitalization trends for Crohn's disease and ulcerative colitis in the 21st century: a systematic review with temporal analyses. Clin Gastroenterol Hepatol 2023; 21: 2211-21.
7. Conrad K, Roggenbuck D, Laass MW. Diagnosis and classification of ulcerative colitis. Autoimmun Rev 2014; 13: 463-6.
8. Porter RJ, Kalla R, Ho GT. Ulcerative colitis: recent advances in the understanding of disease pathogenesis. F1000Res 2020; 9: F1000 Faculty Rev-294.
9. Ka?u?na A, Olczyk P, Komosińska-Vassev K. The role of innate and adaptive immune cells in the pathogenesis and development of the inflammatory response in ulcerative colitis. J Clin Med 2022; 11: 400.
10. Guo XY, Liu XJ, Hao JY. Gut microbiota in ulcerative colitis: Insights on pathogenesis and treatment. J Dig Dis 2020; 21: 147-59.
11. Pei LY, Ke YS, Zhao HH, et al. Role of colonic microbiota in the pathogenesis of ulcerative colitis. BMC Gastroenterol 2019; 19: 10.
12. Larabi A, Barnich N, Nguyen HTT. New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD. Autophagy 2020; 16: 38-51.
13. Shao BZ, Yao Y, Zhai JS, Zhu JH, Li JP, Wu K. The role of autophagy in inflammatory bowel disease. Front Physiol 2021; 12: 621132.
14. Raine T, Bonovas S, Burisch J, et al. ECCO guidelines on therapeutics in ulcerative colitis: medical treatment. J Crohns Colitis 2022; 16: 2-17.
15. Tripathi K, Feuerstein JD. New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance. Drugs Context 2019; 8: 212572.
16. Liu S, Huang Q, Huang Q, et al. The protective effects of electroacupuncture on intestinal barrier lesions in IBS and UC model. Sci Rep 2023; 13: 7276.
17. Wang L, An J, Song S, et al. Electroacupuncture preserves intestinal barrier integrity through modulating the gut microbiota in DSS-induced chronic colitis. Life Sci 2020; 261: 118473.
18. Xu HC, Wu RL, Jiang ZW, et al. Study on the mechanism of electroacupuncture regulating macrophage polarization to improve ulcerative colitis in rats. Zhen Ci Yan Jiu 2023; 48: 1033-40.
19. Martin JC, Bériou G, Josien R. Dextran sulfate sodium (DSS)-induced acute colitis in the rat. Methods Mol Biol 2016; 1371: 197-203.
20. China Association of Acupuncture and Moxibustion. Nomenclature and location of acupuncture points for laboratory animals part 2: rat. World J Acupunct Moxibustion 2024; 35: 163-5.
21. Liu JL, Chen LJ, Liu Y, et al. The gut microbiota contributes to methamphetamine-induced reproductive toxicity in male mice. Ecotoxicol Environ Saf 2024; 279: 116457.
22. Murthy SN, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sedergran DJ. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci 1993; 38: 1722-34.
23. Wirtz S, Popp V, Kindermann M, et al. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc 2017; 12: 1295-1309.
24. Liu Y, Li BG, Su YH, et al. Potential activity of Traditional Chinese Medicine against ulcerative colitis: a review. J Ethnopharmacol 2022; 289: 115084.
25. Lin YY, Zhao JM, Ji YJ, et al. Typical ulcerative colitis treated by herbs-partitioned moxibustion: a case report. World J Clin Cases 2020; 8: 1515-24.
26. Qi Q, Im H, Li KS, et al. Influence of herb-partitioned moxibustion at Qihai (CV6) and bilateral Tianshu (ST25) and Shangjuxu (ST37) acupoints on toll-like receptors 4 signaling pathways in patients with ulcerative colitis. J Tradit Chin Med 2021; 41: 479-85.
27. Cao QR, Ling C, Liu MJ, Zhang H, Deng SF. Electroacupuncture of "Shangjuxu" (ST37) and "Tianshu" (ST25) reduces colonic injury by suppressing NF-κB/NLRP3 signaling in rats with ulcerative colitis. Zhen Ci Yan Jiu 2022; 47: 314-20.
28. Wu HG, Liu HR, Tan LY, et al. Electroacupuncture and moxibustion promote neutrophil apoptosis and improve ulcerative colitis in rats. Dig Dis Sci 2007; 52: 379-84.
29. Sun J, Zhang H, Wang C, et al. Regulating the balance of Th17/Treg via electroacupuncture and moxibustion: an ulcerative colitis mice model based study. Evid Based Complement Alternat Med 2017; 2017: 7296353.
30. Qiu P, Liu L, Fang J, et al. Identification of pharmacological autophagy regulators of active ulcerative colitis. Front Pharmacol 2021; 12: 769718.
31. Gong ZZ, Li T, Yan H, et al. Exploring the autophagy-related pathogenesis of active ulcerative colitis. World J Clin Cases 2024; 12: 1622-33.
32. Cao W, Li J, Yang K, Cao D. An overview of autophagy: Mechanism, regulation and research progress. Bull Cancer 2021; 108: 304-22.
33. Lystad AH, Carlsson SR, Simonsen A. Toward the function of mammalian ATG12-ATG5-ATG16L1 complex in autophagy and related processes. Autophagy 2019; 15: 1485-6.
34. Tanida I, Ueno T, Kominami E. LC3 and autophagy. Methods Mol Biol 2008; 445: 77-88.
35. Komatsu M, Ichimura Y. Physiological significance of selective degradation of p62 by autophagy. FEBS Lett 2010; 584: 1374-8.
36. Hong J. Protective effects of curcumin-regulated intestinal epithelial autophagy on inflammatory bowel disease in mice. Gastroenterol Res Pract 2022; 2022: 2163931.
37. Qiao D, Zhang Z, Zhang Y, et al. Regulation of endoplasmic reticulum stress-autophagy: a potential therapeutic target for ulcerative colitis. Front Pharmacol 2021; 12: 697360.
38. Afzal O, Altamimi ASA, Mubeen B, et al. mTOR as a potential target for the treatment of microbial infections, inflammatory bowel diseases, and colorectal cancer. Int J Mol Sci 2022; 23: 12470.
39. Chen Q, Duan X, Fan H, et al. Oxymatrine protects against DSS-induced colitis via inhibiting the PI3K/AKT signaling pathway. Int Immunopharmacol 2017; 53: 149-57.
40. Liu Y, Deng S, Sun L, et al. Compound sophorae decoction mitigates DSS-induced ulcerative colitis by activating autophagy through PI3K-AKT pathway: a integrative research combining network pharmacology and in vivo animal model validation. J Ethnopharmacol 2025; 337: 118885.
41. Ohkusa T, Koido S. Intestinal microbiota and ulcerative colitis. J Infect Chemother 2015; 21: 761-8.
42. Dai ZF, Ma XY, Yang RL, et al. Intestinal flora alterations in patients with ulcerative colitis and their association with inflammation. Exp Ther Med 2021; 22: 1322.
43. Noor SO, Ridgway K, Scovell L, et al. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol 2010; 10: 134.
44. Stojanov S, Berlec A, ?trukelj B. The influence of probiotics on the firmicutes/bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease. Microorganisms 2020; 8: 1715.
45. Tsai YC, Tai WC, Liang CM, et al. Alterations of the gut microbiota and the firmicutes/bacteroidetes ratio after biologic treatment in inflammatory bowel disease. J Microbiol Immunol Infect 2025; 58: 62-9.
46. Zhu S, Han M, Liu S, Fan L, Shi H, Li P. Composition and diverse differences of intestinal microbiota in ulcerative colitis patients. Front Cell Infect Microbiol 2022; 12: 953962.
47. Wang YN, Meng XC, Dong YF, et al. Effects of probiotics and prebiotics on intestinal microbiota in mice with acute colitis based on 16S rRNA gene sequencing. Chin Med J (Engl) 2019; 132: 1833-42.
48. Huang Z, Zhao Y, Yang W, et al. Amomum tsaoko flavonoids attenuate ulcerative colitis by inhibiting TLR4/NF-κB/NLRP3 signaling pathway and modulating gut microbiota in mice. Front Microbiol 2025; 16: 1557778.
49. Guo S, Geng W, Chen S, et al. Ginger alleviates DSS-induced ulcerative colitis severity by improving the diversity and function of gut microbiota. Front Pharmacol 2021; 12: 632569.
50. Wang C, Xiao Y, Yu L, et al. Protective effects of different Bacteroides vulgatus strains against lipopolysaccharide-induced acute intestinal injury, and their underlying functional genes. J Adv Res 2021; 36: 27-37.
51. Lapaquette P, Bizeau JB, Acar N, Bringer MA. Reciprocal interactions between gut microbiota and autophagy. World J Gastroenterol 2021; 27: 8283-301.
52. Subramanian A, J A, T T, et al. Exploring the connections: autophagy, gut microbiota, and inflammatory bowel disease pathogenesis. J Inflamm Res 2024; 17: 10453-70.
53. Li S, Qian Q, Yang H, et al. Fucoidan alleviated dextran sulfate sodium-induced ulcerative colitis with improved intestinal barrier, reshaped gut microbiota composition, and promoted autophagy in male C57BL/6 mice. Nutr Res 2024; 122: 1-18.
54. Xiao J, Xie L, Zheng B, et al. Polygonatum cyrtonema saponin supplementation ameliorated DSS-induced intestinal barrier injury via targeting the PI3K/AKT/mTOR-mediated autophagy/microbiota axis. Food Biosci 2024; 61: 104727.
55. Dong L, Du H, Zhang M, et al. Anti-inflammatory effect of Rhein on ulcerative colitis via inhibiting PI3K/Akt/mTOR signaling pathway and regulating gut microbiota. Phytother Res 2022; 36: 2081-94.
56. Shen ZH, Zhu CX, Quan YS, et al. Relationship between intestinal microbiota and ulcerative colitis: mechanisms and clinical application of probiotics and fecal microbiota transplantation. World J Gastroenterol 2018; 24: 5-14.
57. Li Q, Ding X, Liu K, et al. Fecal microbiota transplantation for ulcerative colitis: the optimum timing and gut microbiota as predictors for long-term clinical outcomes. Clin Transl Gastroenterol 2020; 11: e00224.
58. Costello SP, Soo W, Bryant RV, et al. Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Aliment Pharmacol Ther 2017; 46: 213-24.
59. Zhang W, Zou G, Li B, et al. Fecal microbiota transplantation (FMT) alleviates experimental colitis in mice by gut microbiota regulation. J Microbiol Biotechnol 2020; 30: 1132-41.
Options
Outlines

/

〈 〉